Clinical Trials In Oklahoma City

Discover hundreds of clinical trials in Oklahoma City.
Search clinical trials in Oklahoma City by condition or phase.

e.g. Respiratory Diseases

Oklahoma City•Healthy volunteers: No

Filter results

Results: 732

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Oklahoma City, Phoenix, Little Rock, Loma Lindashow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Oklahoma City, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Oklahoma City, Little Rock, Anaheim, Antiochshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Birmingham, Boise, Caldwellshow 76 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Oklahoma City, Mesa, Valencia, Clearwatershow 6 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod

e.g. Respiratory Diseases

Oklahoma City•Healthy volunteers: No

Filter results

Results: 732

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Oklahoma City, Phoenix, Little Rock, Loma Lindashow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Oklahoma City, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Oklahoma City, Little Rock, Anaheim, Antiochshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Birmingham, Boise, Caldwellshow 76 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Recruiting

Sponsor:

Pfizer

Location:

Oklahoma City, Mesa, Valencia, Clearwatershow 6 more

Code:

NCT06398626

Conditions

Colitis, Ulcerative

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Etrasimod